Boston Scientific gets early nod for next-gen S-ICD
This article was originally published in Clinica
Executive Summary
The US FDA has approved Boston Scientific's next-generation Emblem S-ICD subcutaneous implantable defibrillator earlier than expected with plans to launch in the US by this fall. The firm has also CE marked the device in Europe.